Study 1 of 27 for search of: "Toothache"
Previous Study Return to Search Results Next Study

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
The Comparison of Supraperiosteal Nerve Block With Opiate Analgesia in Alleviating the Pain of Toothache
This study is not yet open for participant recruitment.
Verified by Albany Medical College, December 2007
Sponsored by: Albany Medical College
Information provided by: Albany Medical College
ClinicalTrials.gov Identifier: NCT00574015
  Purpose

This study will compare the degree of pain control provided by two techniques for persons with toothache in an emergency department. The two techniques include;

  • standard oral narcotic pain medication
  • numbing the tooth with local anesthetic by needle injection

Condition Intervention Phase
Toothache
Drug: hydrocodone/acetaminophen
Drug: bupivacaine (supraperiosteal nerve block)
Phase IV

MedlinePlus related topics: Anesthesia
Drug Information available for: Acetaminophen Bupivacaine Bupivacaine hydrochloride Hydrocodone Hydrocodone bitartrate Vicodin
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title: The Comparison of Supraperiosteal Nerve Block With Opiate Analgesia in Alleviating the Pain of Toothache

Further study details as provided by Albany Medical College:

Primary Outcome Measures:
  • VAS determination of pain at 30 minutes following intervention [ Time Frame: 30 minutes ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Numeric scale report or pain Number of prescribed analgesic pills taken [ Time Frame: 24-36 hours following intervention ] [ Designated as safety issue: No ]

Estimated Enrollment: 60
Study Start Date: December 2007
Estimated Study Completion Date: December 2008
Arms Assigned Interventions
oral: Active Comparator
administration of oral analgesia
Drug: hydrocodone/acetaminophen
oral hydrocodone 10 mg/acetaminophen 650 mg
Dental Block: Experimental
Administration of supraperiosteal nerve block to effected tooth
Drug: bupivacaine (supraperiosteal nerve block)
Administration of Bupivacaine 0.5% 2 ml adjacent to tooth root

Detailed Description:

Background: Toothache is a common complaint among patients presenting to the emergency department. There are two commonly employed methods of alleviating this severe form of pain. Oral opioid analgesia is the most commonly utilized strategy for treating this pain. However, many emergency physicians and dentists employ a local anesthetic technique known as supraperiosteal nerve block. This study will compare the relative efficacy of these techniques.

Patients meeting enrollment criteria will be randomized to either receive a supraperiosteal nerve block or oral hydrocodone 10 mg/acetaminophen 650 mg. They will otherwise be managed identically. Reduction of pain scores between entry and 30 minutes post intervention will be compared as well as numeric pain scores obtained by phone contact 24 hours later. Secondary outcomes will include the proportion of individuals from each group filling prescriptions for pain medication and the number of pain pills taken.

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Involvement of a single tooth
  • Percussive tenderness of the crown of the suspect tooth

Exclusion Criteria:

  • Age younger than 18 years
  • Women who are breast feeding
  • Allergy or intolerance to hydrocodone, bupivacaine or acetaminophen
  • Pregnancy
  • Involvement of multiple teeth
  • Pain resulting from pericoronitis.
  • Pain resulting from dental trauma occurring less than 90 days prior
  • Pain of more than 96 hours duration
  • Facial or neck swelling or tenderness
  • Alteration in phonation
  • Cognitive impairment
  • Concurrent use of opiate analgesics
  • Impairment of liver function
  • Consumption of more than 4 grams of acetaminophen in the past 24 hours.
  • Patients who are visually impaired.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00574015

Contacts
Contact: Wayne R Triner, DO, MPH 518-262-3773 trinerw@mail.amc.edu

Locations
United States, New York
Albany Medical Center Hospital
Albany, New York, United States, 12208
Sponsors and Collaborators
Albany Medical College
Investigators
Principal Investigator: Wayne R Triner, DO, MPH Albany Medical College
  More Information

Responsible Party: Emergency Medicine, Albany Medical College ( Wayne Triner, DO, MPH )
Study ID Numbers: 2200, 2200
Study First Received: December 13, 2007
Last Updated: December 13, 2007
ClinicalTrials.gov Identifier: NCT00574015  
Health Authority: United States: Institutional Review Board

Keywords provided by Albany Medical College:
toothache
regional anesthesia
emergency department

Study placed in the following topic categories:
Tooth Diseases
Facial Pain
Facies
Toothache
Pain
Naphazoline
Oxymetazoline
Signs and Symptoms
Guaifenesin
Phenylephrine
Hydrocodone
Emergencies
Bupivacaine
Phenylpropanolamine
Stomatognathic Diseases
Acetaminophen

Additional relevant MeSH terms:
Respiratory System Agents
Physiological Effects of Drugs
Anesthetics
Central Nervous System Depressants
Narcotics
Pharmacologic Actions
Anesthetics, Local
Analgesics, Non-Narcotic
Sensory System Agents
Therapeutic Uses
Analgesics
Peripheral Nervous System Agents
Antitussive Agents
Central Nervous System Agents
Analgesics, Opioid

ClinicalTrials.gov processed this record on January 16, 2009